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Abstract
Skin is one of the largest human organ systems whose primary purpose is the protection of deeper tissues.
As such, the skin must maintain a homeostatic balance in the face of many microenvironmental and
genetic perturbations. At its simplest, skin homeostasis is maintained by the balance between skin cell
growth and death such that skin architecture is preserved. This study presents a hybrid multiscale
mathematical model of normal skin (vSkin). The model focuses on key cellular and microenvironmental
variables that regulate homeostatic interactions among keratinocytes, melanocytes and fibroblasts, key
components of the skin. The model recapitulates normal skin structure, and is robust enough to withstand
physical as well as biochemical perturbations. Furthermore, the vSkin model revealed the important role
of the skin microenvironment in melanoma initiation and progression. Our experiments showed that
dermal fibroblasts, which are an important source of growth factors in the skin, adopt a phenotype that
facilitates cancer cell growth and invasion when they become senescent. Based on these experimental
results, we incorporated senescent fibroblasts into vSkin model and showed that senescent fibroblasts
transform the skin microenvironment and subsequently change the skin architecture by enhancing the
growth and invasion of normal melanocytes as well as early stage melanoma cells. These predictions
are consistent with our experimental results as well as clinical observations. Our co-culture experiments
show that the senescent fibroblasts promote the growth and invasion of non-tumorigenic melanoma cells.
We also observed increased proteolytic activity in stromal fields adjacent to melanoma lesions in human
histology. This leads us to the conclusion that, senescent fibroblasts create a pro-oncogenic environment
that synergizes with mutations to drive melanoma initiation and progression and should therefore be
considered as a potential future therapeutic target. This study suggests a potential link between aging
in the skin microenvironment and the development of melanocytic neoplasms.
Author Summary
Skin homeostasis depends upon the complex interplay of skin cells as well as interactions between cells and
the microenvironment. Here, we generated a virtual skin (vSkin) model in order to test our hypothesis
that dysregulation of cell-microenvironment interaction leads to aberrant skin structure and furthermore
recapitulates pathologic conditions of the skin. To this end, we used the hybrid cellular automata method.
The model couples a cellular automata that describes biological rules for cell types with partial differential
equations that describe continuous microenvironmental factors. Our simulation recapitulated normal
skin growth as well as self-repair. It also showed that microenvironmental factors produced by stromal
cells (fibroblasts) play an important role in maintaining normal skin homeostasis. We find that the
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2transdifferentiation of fibroblasts due to senescence changes the skin microenvironment to drive melanoma
initiation and progression. Our model gives new insights into the processes of melanoma initiation and
progression, and suggests a novel strategy for treatment.
Introduction
Skin is the largest organ of the body. It is a physical barrier that limits the flow of water and electrolytes,
while providing protection from ultraviolet radiation, microorganisms and toxic substances. Human skin
consists of three layers, the epidermis, dermis, and subcuits. The epidermis consists of keratinocytes,
melanocytes, Langerhans cells and Merkel cells. The dermis is composed of connective tissue, fibroblasts,
blood vessels and lymphatics. The subcutis is made up of loose connective tissue and insulating fat
cells. Keratinocytes are the main constituent of the epidermis, composing around 95% of the total cell
number [1]. Within the epidermis the keratinocytes form a stratified squamous epithelium in which the
keratinocytes are tightly connected to each other through desmosomes. Like other epithelial tissue, the
epidermis continuously renews itself. In the epidermis, cell proliferation occurs at the basal layer followed
by a stepwise upward migration and maturation of the cells. As the keratinocytes mature they lose their
nuclei and turn into keratin-filled corneocytes that form a 10-30 cell thick water resistant protective layer
that gives the skin its critical barrier function. Protection of the keratinocytes from the DNA-damaging
effects of ultraviolet radiation is mediated by the pigment producing cells, melanocytes, which locate to
the basement membrane of the skin in a 1:5 ratio with the basal keratinocytes [2, 3]. Upon exposure to
UV radiation, melanocytes produce melanin which is transferred to the surrounding keratinocytes via an
active transport process. Once taken up into keratinocytes, melanosomes orientate themselves over the
nucleus in a protective “hat” that shields the nuclei of the basal keratinocytes from UV-induced DNA
damage [4]. Keratinocytes in turn regulate the growth and behavior of melanocytes through a complex
network of cell-cell adhesion proteins and secretory factors [3]. In addition to these interactions, the
structure and strength of skin is also critically dependent upon the extracellular matrix (ECM) and the
fibroblasts in the dermis. Dermal fibroblasts secrete ECM components and are responsible for mechanical
strength of the dermis [5] as well as producing growth factors such as epidermal growth factors (EGF),
transforming growth factor β (TGFβ), and basic fibroblast growth factor (bFGF) [6]. These growth
factors promote growth and facilitate the constant renewal of the epidermis.
Melanoma is the most devastating form of skin cancer [7, 8], arising from the malignant transforma-
tion of melanocytes. The first phenotypic change in melanocytes is the disruption of growth controls and
development of melanocytic nevi, a benign mole. At the molecular level, the growth is stimulated by the
abnormal activation of the mitogen-activated protein kinase (MAPK) signaling pathway which can arise
through activating mutations in the NRAS (15% of melanomas) or BRAF (50% of melanomas) [9–12].
Despite BRAF mutations being important for melanoma development, the majority of benign nevi also
harbor BRAF mutations [13] and rarely undergo full malignant transformation. Instead, benign nevi
cease proliferation and remain quiescent for decades, entering a state of oncogene-induced senescence
(OIS) [14, 15]. This suggests that nevi must acquire additional intrinsic (molecular) or extrinsic (mi-
croenvironmental) damages to free themselves from the OIS state and develop into full-blown malignant
melanoma. There is some suggestion that activation of phosphoinositide 3-kinase (PI3K)/protein kinase
B (PKB or AKT) due to loss of a tumor-suppressor gene, phosphatase and tensin homologue (PTEN) may
be required for escape from senescence [16]. The suggested mechanism is that the inactivation of PTEN
fails to attenuate the PI3K/AKT level, and consequently increases PI3K/AKT expression that facilitates
cell proliferation and survival. However, the precise molecular events that underlie the transformation of
nevus cells develop into melanoma are not well understood.
Cancer is typically a disease of old-age, and there is increasing evidence that senescence within the
stroma, particularly in the fibroblast compartment can drive tumor development. A number of reports
have shown that senescent stromal fibroblasts stimulate premalignant and malignant epithelial cells to
3grow in cell culture and to form tumors in mice [17–20]. Mechanistically, this seems to involve the secretion
of factors from senescent fibroblasts, such as Matrix metalloproteinase-3 (MMP-3) and Interleukin-6 (IL-
6), that in turn remodel the microenvironment, alter epithelial differentiation, promote endothelial cell
motility and stimulate cancer cell growth both in vitro and in vivo [21,22]. It is well known that aged skin
tends to harbor large numbers of senescent fibroblasts [23], and there is a direct correlation between age
and the expression of p16INK4A (a cell cycle inhibitor) expression within the dermis [24]. In other words,
concentrations of p16INK4A increase dramatically as tissue ages. Photo-damage following exposure to
UV radiation can also increase the level of senescence within the skin through the effects of oxidative
damage upon the telomeres shortening [25,26]. Although the exact role of the dermal microenvironment
in melanoma development has been little studied, there is evidence that the mildly hypoxic environment
of the skin contributes to melanocyte transformation [27]. It is also known that fibroblasts contribute
towards the survival of early-stage melanoma cells by secreting the growth factor IGF-1 and that stromal
remodeling through TGFβ overexpression can enhance melanoma survival in mice [28].
In order to gain a better insight into the mechanisms underlying normal skin homeostasis, and ul-
timately the role of the stroma in melanoma initiation and progression, we developed a virtual skin
model. Several computational studies of skin have recently been developed. Deterministic ordinary dif-
ferential equations have been used to model immune signaling in human skin, providing a quantitative
strategy that distinguishes healthy from pathologic inflammatory responses [29]. A similar method has
been employed to model mouse embryonic melanoblast proliferation dynamics [30]. Another continuous
modeling framework, a system of deterministic reaction-diffusion equations, has been applied to model
tumor-immune interactions [31]. A continuum fluid mechanics approach has been adopted to analyze the
stability of the interface between epithelia and stroma [32]. A mixture theory has been used for structure
stability analysis of melanoma growth [33] and microstructure patterning [34]. More discrete based mod-
eling frameworks have also been applied to model skin. Agent based methods have been used to model
epidermal keratinocyte behavior in normal skin [35–37], epidermal homeostasis control [38], keratinocyte
originated skin disease [39], the interactions between keratinocytes and fibroblasts [40], and melanocyte
distribution in epidermis [41]. However, none of these previous studies have considered normal skin
homeostasis and its disruption as a route to melanoma development.
In this study, we have developed a hybrid multiscale mathematical model that simulates normal
skin homeostasis. We named the model virtual skin (vSkin). We employed a hybrid cellular automata
(HCA) approach [42–45]. The general modeling approach is to derive a set of rules for discrete cells and
couple this discrete cellular population with a suite of continuous microenvironmental factors. Previously,
we have applied this method to investigate tumor-stroma interactions in prostate cancer progression [46].
In this study, we developed a minimal set of cell rules for melanocytes, keratinocytes, and fibroblasts,
which determine each cell’s life cycle. Then, we developed a cell interaction network that defines local
interactions between cells and their microenvironment. These local interactions lead to the emergence
of normal skin structure that recapitulates the in vivo structure of skin. Using our model, we observed
that the vSkin model is robust enough to withstand perturbations. The vSkin model not only recovers
from massive loss of its constituents but also finds an equilibrium state after super-physiological per-
turbations of microenvironmental factors. The proposed model also reveals the possible involvement of
these microenvironmental factors in conjunction with senescent stroma in driving melanoma initiation
and progression.
The paper is organized as follows. In the first section, we give an overview of the vSkin model
development process. In the second section, we initially present results showing the stability of vSkin.
Then, we discuss the robustness of the vSkin as well as application of the model to melanoma initiation
via melanocyte mutation and fibroblast transdifferentiation. We conclude with a discussion focusing on
the implications of the model predictions in terms of a novel strategy for treatment.
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Figure 1. Human skin normal structure. A: H & E stained cross-section of human normal skin at
20X showing the epidermis contains a basal layer, melanocytes and keratinocytes. The dermis contains
fibroblasts and extracellular matrix. B: Model domain with its key cell types such as keratinocyte,
melanocyte and fibroblasts. The density of extracellular matrix is considered and assumed to be
continuous in the domain. The gray color represents the density of extracellular matrix at each node in
the domain, i.e., darker gray represents denser matrix. The basement membrane separates epidermis
and dermis layer in the model, and it is represented by continuously connected nodes where the density
of matrix has reached its maximum (1.0).
Material and methods
Mathematical model
We propose a systemic model of skin capable of growth control as well as self-repair. In this section, we
describe the development of the vSkin model, which represents a cross-section of skin as shown in Figure
1. We first present key microenvironmental variables involved in normal skin structure and function.
Then we move on to discuss the implementation of key cell phenotypes.
Hybrid cellular automata model
In order to keep the complexity of the model to a minimum, we only consider three key cell types critical
for skin function, melanocytes, keratinocytes, and fibroblasts. These cells are defined as points on a two-
dimensional grid that represents a cross-section of human skin (6 mm×1.24 mm), as shown in Figure 1B.
Each grid point may also be occupied by up to five microenvironmental variables, EGF, bFGF, TGFβ ,
MMPs, and basement membrane/ECM. The discrete cells are coupled with these microenvironmental
concentrations to define the hybrid cellular automata (HCA) model. The cells on the lattice influence
these microenvironmental concentration fields through production and consumption, but are in turn
affected by the concentrations, as they serve as regulators of cell behavior. To better understand how these
cells interact with one another and their microenvironmental variables we developed a cell interaction
network (Figure 2). This network shows the key interactions that are believed to be important in
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Figure 2. Cell interaction network for normal skin. Green lines represent promoting events,
while red lines imply inhibiting effects. Note, cell coloration is used in all simulations to represent the
equivalent cell. In the model, a fibroblast is assumed to produce three growth factors, Epidermal
growth factor (EGF), Basic fibroblast growth factor (bFGF) and Transforming growth factor (TGFβ).
EGF promotes growth of keratinocytes, whilst TGFβ inhibits the growth. The growth of melanocyte is
controlled by both bFGF and physical interaction (contact inhibition) with neighboring keratinocytes.
maintaining normal skin structure and function. The network was derived through lengthy discussion
with our experimental co-authors and an extensive literature review, detailed throughout the following
sections.
Microenvironmental factors
Keratinocytes, melanocytes and fibroblasts require a large number of different growth factors and adhe-
sion signals to promote and maintain their normal growth and maintenance. However, here we restrict
ourselves to either one or two chemical variables for each cell type in the model for the sake of simplicity.
For a keratinocyte, we consider EGF and TGFβ , because these two factors are known to be the most
effective regulators for keratinocyte growth control [47–51]. We consider bFGF for the growth control
of both melanocytes [52] and fibroblasts [53]. Since fibroblasts produce protease when they are acti-
vated [5, 6], we include MMP in the model as well. Finally, ECM concentration is incorporated, since
ECM is required for structural support, and it separates the dermal and epidermal layers [1, 5] in the
form of basement membrane. The dynamics of the five microenvironmental variables are defined by a
system of partial differential equations that describe how each of them evolves in space and time. Since
these continuous variables interact with discrete cells, for clarity we present only the discretized version
of each equation.
6The discretized governing equation for EGF (GE) at a node η ≡ (ηx, ηy) ∈ Ω ⊂ Z2 is
[GE ]
+1 − [GE ]
δt
=
diffusion︷ ︸︸ ︷
DE∆2[GE ] +
production by
fibroblasts and keratinocytes︷ ︸︸ ︷
(αEFη + βEKη) −
binding to EGF receptors of
keratinocytes or melanocytes︷ ︸︸ ︷
(γEKη[GE ] + ζEMη[GE ])−
decay︷ ︸︸ ︷
λ[GE ], (1)
where
Xη =
{
1 if a node η is occupied by a cell type X at time step t,
0 otherwise,
where a cell type X can be keratinocyte (K), melanocyte (M) or fibroblast (F ). In Eq (1), [·] represents
the concentration of a chemical at a node η at time step t (e.g.,[GE ] = GE(t, ηx, ηy)), [·]+1 represents
the concentration at the next time step, and δt represents a time step. The operator ∆2 defines a
two-dimensional discrete Laplacian,
∆2f(t, ηx, ηy) ≡ f(t, ηx + δh, ηy) + f(t, ηx − δh, ηy) + f(t, ηx, ηy + δh) + f(t, ηx, ηy − δh)− 4f(t, ηx, ηy)
(δh)2
,
where δh is the grid size. Equation (1) defines EGF as a diffusing chemical which is increased by a rate
of αE or βE when a grid node η is occupied by a fibroblast (F ) or a keratinocyte (K), respectively. The
concentration is decreased if a node is occupied by a keratinocyte or melanocyte (M) at a rate of γE and
ζE , respectively, due to uptake of EGF. Lastly, the concentration has a natural decay rate of λ per time
step. Similarly, the dynamics of bFGF (Gb) is modeled as follows,
[Gb]
+1 − [Gb]
δt
=
diffusion︷ ︸︸ ︷
Db∆2[Gb] +
production by fibroblasts, keratinocytes,
abnormal fibroblasts and transformed melanocytes︷ ︸︸ ︷
(αbFη + βbKη + α
s
bF
s
η + β
s
bM
s
η )
−
binding to bFGF receptors of keratinocytes,
melanocytes, fibroblasts, transformed melanocytes, and abnormal fibroblasts︷ ︸︸ ︷
(γbKη[Gb] + ζbMη[Gb] + ξbFη[Gb] + ζ
s
bM
s
η [Gb] + ξ
s
bF
s
η [Gb])−
decay︷ ︸︸ ︷
λ[Gb],
(2)
where fibroblasts and keratinocytes produce bFGF at the rate of αb and βb, respectively, and transformed
fibroblasts and transformed melanocytes produce bFGF at the rate of αsb and β
s
b , respectively. All cell
types bind to bFGF at a rate of γb, ζb, ξb, ζ
s
b , and ξ
s
b . Finally, TGFβ (Tβ) is produced by fibroblasts and
keratinocytes at a rate of αTβ and βTβ , respectively, diffuses at a rate DTβ , and binds to keratinocytes,
melanocytes (or transformed melanocytes), fibroblasts (or abnormal fibroblasts) at rates of γTβ , ζTβ , ξTβ ,
respectively.
[Tβ ]
+1 − [Tβ ]
δt
=
diffusion︷ ︸︸ ︷
Dβ∆2[Tβ ] +
production by
fibroblasts and keratinocytes︷ ︸︸ ︷
(αTβFη + βTβKη)
−
binding to TGFβ receptors of
keratinocytes, melanocytes, fibroblasts, transformed melanocytes, and abnormal fibroblasts︷ ︸︸ ︷
(γTβKη[Tβ ] + ζTβMη[Tβ ] + ξTβFη[Tβ ] + ζTβM
s
η [Tβ ] + ξTβF
s
η [Tβ ]) −
decay︷ ︸︸ ︷
λ[Tβ ] .
(3)
ECM (E) is produced by both fibroblasts or keratinocytes depending on the local concentration of
ECM. In other words, keratinocytes and fibroblasts produce ECM with a rate of κE and ρE only if there
is any loss compared to the initial density of epidermis (E0) and dermis (E1), respectively. However,
transformed fibroblasts always produce ECM with a rate of ρsE . Whenever fibroblasts are in contact with
keratinocytes or melanocytes, fibroblasts can make much denser matrix which will create new basement
7membrane [54]. Basement membrane (BM) is defined as a continuously connected curve of grid points,
each of whose ECM densities is maximal (taken to be 1 in non-dimensional units). ECM is degraded by
MMP at a rate of µ. The governing equation for ECM is
[E]+1 − [E]
δt
=
production
by keratinocytes︷ ︸︸ ︷
κEH(E0 − [E])Kη +
production
by fibroblasts︷ ︸︸ ︷
ρEH(E1 − [E])Fη +
production
by abnormal fibroblasts︷ ︸︸ ︷
ρsEF
s
η −
degradation
by MMP︷ ︸︸ ︷
µ[P ][E] (4)
where E0 represents initial density of epidermis and E1 is that of dermis. Note that when a fibroblast is
in contact with either a melanocyte or a keratinocyte, we set E1 to be its maximal value 1.0 to model
fibroblast’s basement membrane generation. The function H is the Heaviside step function defined as
H(x) =
{
0 if x ≤ 0
1 if x > 0.
(5)
MMPs (P) are produced by abnormal fibroblasts, diffuse at a rate Dp, and are depleted as they degrade
the ECM (E). Note that when melanocytes are transformed, they can produce MMPs as well. In the
model, we assume that transformed melanocytes produce MMPs with a rate of βsp. The governing
equation is
[P ]+1 − [P ]
δt
=
diffusion︷ ︸︸ ︷
Dp∆2[P ] +
production
by abnormal fibroblasts︷ ︸︸ ︷
αspF
s
η +
production
by transformed melanocytes︷ ︸︸ ︷
βspM
s
η −
degradation
by MMP︷ ︸︸ ︷
µ[P ][E]. (6)
All boundary conditions for all microenvironmental variables are no-flux on the surface and the bottom
of the domain. Periodic boundary conditions were imposed on the left and right sides of the domain.
Cell phenotypes
The behavior of each cell depends on its neighbors and the microenvironmental concentrations in which it
resides. In the vSkin model, we consider the von Neumann neighborhood of range 1 (i.e., four orthogonal
neighbors) for each grid point η ∈ Ω, denoted by N η. In vSkin, each cell has three possible phenotypes:
proliferative, migratory and dead. In this section, we describe how these phenotypes are implemented.
Biological rules for each cell were abstracted from a literature review and are summarized as flowcharts
in Figure 3. For the sake of simplicity, each cell is allowed to execute only one phenotype, proliferative,
migratory, or dead, at each cell time step (tc). In other words, if the cell chooses one phenotype at current
time step, it exits current life cycle and waits until next time step. If a cell does not execute any of these
three phenotypes, it remains as a quiescent cell.
Cell-cell adhesion: In order to incorporate one of the important mechanical aspects of skin into the
model, we define an adhesion level (0 ≤ Aη ≤ 1) at each node η ∈ Ω explicitly by using cell-cell adhesive
coefficients Cη,ξ, where ξ is one of its orthogonal neighbors (i.e. ξ ∈ Nη). The adhesive coefficient between
the same cell types is defined as 0.5. A value zero is assigned when there is no known adhesion mechanism
between two cells, such as between a fibroblast and a keratinocyte. The coefficient for two melanocytes
is based on current literature [3, 55]. To model E-cadherin mediated adhesion between a keratinocyte
and a melanocyte, we impose a higher value (1) between these cell types. To recapitulate the anchorage
of a melanocyte to the basement membrane, we also assign a higher value (1). The adhesive coefficient
Cη,ξ for all cases is summarized in Figure 4 A-B. By averaging the four adhesion coefficients Cη,ξ at each
grid point, we define an adhesion level Aη for a cell at that grid point η.
Aη =
∑
ξ∈Nη
Cη,ξ/4.0. (7)
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Figure 3. Flowcharts showing the cell life cycle for fibroblasts, keratinocytes and
melanocytes. A: Fibroblasts produces bFGF, EGF and TGFβ , and proliferate if there is enough
bFGF. Low concentrations of bFGF trigger fibroblast death. B: Keratinocytes produces bFGF, and
proliferate when there is enough EGF and a low concentration of TGFβ . An insufficient level of EGF
triggers keratinocyte death. C: Melanocyte start their life cycle by checking the melanin unit (the
number of keratinocyte neighbors) and then decide to migrate or not. Sufficient bFGF stimulates
melanocyte proliferation while insufficient bFGF triggers cell death.
Migration: In vSkin, every cell has capacity to move to one of its orthogonal neighbors (Nη) regulated
by its cell-cell adhesion restriction (i.e., Pr(migration) ∼ (1−Aη)), where Aη is a cell-cell adhesion level
obtained from equation (7). Since the migration rules are slightly different for each cell type we will give
a more detailed description in the following paragraphs.
Both keratinocytes and fibroblasts move only if empty grid points exist in Nη. We first determine
the cell-cell adhesion value (Aη). If there is only one empty neighbor in the neighborhood Nη, the cell
moves to this point with probability (1−Aη). If there are more empty grid points, the new position for
the cell is chosen randomly from these grid points. An example of keratinocyte migration is shown in
Figure 4C-D.
In addition to the cell-cell adhesion restriction, we use more complex rules for melanocyte migration
based on the current literature [2,3]. Melanocytes locate to the basement membrane in a 1:5 stable ratio
with basal keratinocytes. Typically, one melanocyte is associated with approximately 36 keratinocyte
neighbors. This symbolic structural relationship is known as the melanin unit. In the vSkin model, this
melanin unit is modeled as a number of keratinocytes in the upper half of the Moore neighborhood of
range γ for each melanocyte. The value of γ is set to 4 in vSkin. In vSkin, a melanocyte is moved to
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Basement
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Figure 4. Cell-cell adhesion and migration A: The cell-cell adhesion value Aη at each node is an
average of its four orthogonal cell-cell adhesive coefficients (Cη,ξE,..,S , defined in B). C: An example of
cell-adhesion level for a keratinocyte at a grid point η. This keratinocyte happens to have one
keratinocyte and one melanocyte neighbor, from (7) an adhesion value Aη is determined (Aη = 0.375).
D: This keratinocyte can move to either the north or south grid point (empty) with the same
probability of Pr = (1−Aη)/2 = 0.3125. E: Another example, where a melanocyte happens to have
three neighbors (east:melanocyte, south:keratinocyte, west:fibroblast) which gives a cell-adhesion value
of 0.5. F: The probability of movement for this melanocyte is 0.5 (i.e. (1−Aη)) and the cell can move
to either its north or south grid point. However, since there is an ECM gradient ([E](south) > [E](η)
but [E](north) < [E](η))the melanocyte is not allowed to move north and therefore can only move
south. ECM gradient will always dictate the movement direction, provided one exists and their is
sufficient space to move.
one of its orthogonal neighbors with regards to its cell-cell adhesion level, provided that (i) the melanin
unit of the melanocyte is disrupted, (ii) there is an ECM gradient towards one of its neighbors, and (iii)
at least one of its neighbors is either empty or only occupied by a keratinocyte. In order to satisfy (i),
a check for the number of keratinocyte neighbors is made every cell time step. Rule (ii) is implemented
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because melanocytes are known to have a delicate cell-matrix interaction mechanism [56,57] and migrate
via haptotaxis. Based on rule (iii), a melanocyte is allowed to be moved to another grid point ξ in Nη even
if the point is occupied by a keratinocyte. This additional rule is implemented to recapitulate observed
melanocyte high motile activity [56]. If there exist one neighbor (ξ) satisfying rule (ii) and (iii), the
melanocyte is moved to the new position ξ. If more than one such neighbors exist, the new position for
the melanocyte is chosen randomly from the neighbors. An example of melanocyte migration is provided
in Figure 4E-F.
Proliferation: In the vSkin model, we assume that each cell has capacity for proliferation and will produce
two daughter cells provided that (i) the cell specific growth factor is sufficient for cell growth and (ii) there
is sufficient space surrounding the parent cell for the two daughter cells to occupy. For a keratinocyte
to divide, the concentration of GE has to be sufficient (GE > Bk) for its division. Then, a keratinocyte
proliferates with a probability of Pr(keratinocyte division) ∼ (1 − Tβ). A melanocyte proliferates if (i)
the melanin unit is disrupted and (ii) the concentration of bFGF is sufficient for cell division (Gb >
Bm). A fibroblast is allowed to proliferate if the growth factor bFGF (Gb) is greater than the threshold
(Bf ). In addition to the bFGF level, we also consider a space constraint that limits the number of
fibroblasts in vSkin domain. A fibroblast can divide only if at most one fibroblast neighbor exists in its
neighborhood. This is not an unreasonable assumption in that the main role of fibroblasts in the model
is to supply microenvironmental factors and the number of fibroblasts and the production rate of the
microenvironmental factors are scalable. In other words, we can first choose a fixed number of normal
fibroblasts in the model and then scale the production rates (αE , αb, αTβ ) accordingly. In order to satisfy
(ii), we assumed that one daughter cell replaces the parent cell and the other daughter cell will move to
any one of the parent cell’s four empty orthogonal neighbors (Nη). If more than one of the neighboring
grid points is empty, then the new cell position is chosen randomly from these points.
Death: For any cell to survive, it requires sufficient growth factors. We assume that the concentration has
to drop to starvation levels, Sk for a keratinocyte and Sm for a melanocyte, before death can occur. For
a normal fibroblast, we use a different constraint that incorporates both cell age and the concentration
of bFGF. Since every fibroblast is continuously producing bFGF with the rate αb, it is never deprived of
growth factor in normal skin conditions. We make another assumption that as a fibroblast ages, it will
need more growth factors. In other words, the probability of fibroblast death is positively correlated with
age but has a reciprocal relationship to the concentration of bFGF (Pr(fibroblast death) ∼ [Gb]/age).
The space that dead cells occupy immediately becomes available to new cells.
HCA Algorithm
We now summarize the computational algorithm that integrates the discrete cells and the continuous
microenvironmental variables.
1. Define a rectangular grid (Ω) that determines both microenvironmental concentrations and cell
positions.
2. Set initial concentration of EGF, bFGF, TGFβ and ECM at each node η ∈ Ω.
3. Place fibroblasts, melanocytes and keratinocytes on the grid.
4. Microenvironmental concentrations are solved using the governing equations (1) - (6).
5. Cell-cell adhesion level Aη is determined for each η ∈ Ω.
6. The concentration of microenvironmental factors and adhesion level are coupled with each cell to
determine its phenotype.
7. Action associated with the determined phenotype is realized and the grid is updated accordingly.
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8. Go to step 4.
Parameterization
This vSkin model inevitably contains a large number of parameters as it has three different cell types
and five microenvironmental factors. Unfortunately, many of the model parameters were difficult, if not,
impossible to obtain, and therefore need to be estimated. However, due to the interdependent nature
of the variables, precise parameterization may not be as important, rather the interactions between the
variables is the real driving force. Homeostasis is our primary goal and as such served as central driver
for parameterization. We do not doubt that other parameter sets could achieve similar outcomes. Note
that all parameters are non-dimensionalized [45].
The diffusion rate of EGF (DE) is estimated using the relation given in [58] with the molecular
weight 133.07 kDa [59]. The estimated value is DE = 2.5 × 10−8 cm2/s. The production rate of
EGF by a fibroblast has not been measured. Thus, we estimate it to be a 0.5 (dimensional value =
1.2 fg day−1cell−1) from multiple simulations varying this parameter within range of [0,1] to achieve
normal growth (net growth ∼ 0) of keratinocytes. Fibroblasts are the main growth factor supplier in
skin [5, 6]. Thus, we make an assumption that a keratinocyte produces EGF with a significantly smaller
rate (0.005; non-dimensional). Growth factor consumption rates are difficult to measure, especially at
the level of single cells. We consider a normal activity rate of growth factor receptors. For example,
we use 0.01 for a normal activation rate of EGF receptors of keratinocytes, meaning that a keratinocyte
is able to bind 1% of EGF at the grid point (per cell) per time step. The rate is set to be a smaller
value (0.001) for melanocytes since EGF is known to stimulate keratinocyte growth mainly [47, 48].
Note that we varied these consumption rates within a range [0, 1] to achieve skin homeostasis. We
estimate the diffusion rate of TGFβ using the relation in [58] and the molecular weight 44.3112 kDa [59].
The estimated value is DTβ = 5.8 × 10−8 cm2/s. The production rate of TGFβ by a fibroblast is
chosen to be 0.21333 fg day−1cell−1 from in vitro study [60]. The rate for a keratinocyte is assumed
to be significantly smaller than that of a fibroblast [61]. Since TGFβ is known to mainly regulate the
growth of keratinocytes [49–51], we assumed that keratinocytes bind to TGFβ the most. The rates for a
melanocyte and a fibroblast were estimated to achieve normal skin homeostasis. The consumption rates
of TGFβ are estimated to be 0.2, 0.6, 0.1 for a melanocyte, a keratinocyte, and a fibroblast, respectively.
Using the same method [58] with molecular weight 17.1531 kDa, the diffusion rate Db is estimated to be
1.2×10−7 cm2/s. The production rate of bFGF by a fibroblast is also estimated from multiple simulations
varying these parameters within a range of [0,1] (non-dimensional). The estimated parameter is 0.05 (0.12
fg day−1cell−1). The rate for keratinocytes is assumed to be significantly smaller, since keratinocytes
appear to produce significantly less bFGF than fibroblasts [62]. Since both melanocytes and fibroblasts
use bFGF as a growth promoting signal and there is no evidence showing which cell binds to bFGF more,
we use the same value (0.02) for the bFGF binding rate. The rate for keratinocytes is set to be significantly
smaller (0.005). The diffusion rate of MMP is estimated to be Dp = 5.01 × 10−8 cm2/s in [58, 59]. The
production rate of MMP by fibroblasts is varied within a range 0.024 - 0.12 fg day−1cell−1. Estimates
for the kinetic parameters λ and µ are not available since they are very difficult to obtain experimentally.
Thus, we set non-dimensional values that best produced homeostasis. We know that ECM density in
the dermis is significantly higher than that in the epidermis (Figure 1), we therefore set the epidermal
ECM density to 0.2 and the dermal ECM density is 0.7. All of the parameter values described here are
summarized in Table 1.
The cell cycle time is set it to be a typical value tc = 24 h. The size of the grid is set to be 300× 62.
The grid size δh is set to be δh = 20 µm (a typical cell diameter), and thus the dimensions of the skin
slice we simulate are 6 mm × 1.24 mm. The time step for the microenvironmental variables is set to
be δt = 4.8 h. We assume that all cell types have the same volume 3.1416 × 10−9 cm3 with a radius
10 µm, and therefore the base number of cells is set to be 3.1831 × 108. The background density of
ECM is set to be 5.0×10−4g cm3 [63]. The background concentration of microenvironmental variables is
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Table 1. Model parameters
Parameter Description Value Normalized value
DTβ Diffusion rate of TGFβ 5.8× 10−8 cm2/s [58,59] 0.0838
αTβ Fibroblast TGFβ production rate 0.21333 fg day
−1cell−1 [60] 0.0873
βTβ Keratinocyte TGFβ production rate 0.0106 fg day cell
−1 0.004
γTβ Keratinocyte TGFβ binding rate − 0.6
ζTβ Melanocyte TGFβ binding rate − 0.2
ξTβ Fibroblast TGFβ binding rate − 0.1
DE Diffusion rate of EGF 2.5× 10−8 cm2/s [58,59] 0.0367
αE Fibroblast EGF production rate 1.2 fg day cell
−1 0.5
βE Keratinocyte EGF production rate 0.0012 fg day cell
−1 0.005
γE Keratinocyte EGF binding rate − 0.01
ζE Melanocyte EGF binding rate − 0.001
Db Diffusion rate of bFGF 1.2× 10−7 cm2/s [58,59] 0.1708
αb Fibroblast bFGF production rate 0.12 fg day cell
−1 0.05
βb Keratinocyte bFGF production rate 0.024 fg day cell
−1 0.01
ξb Fibroblast bFGF binding rate − 0.02
γb Keratinocyte bFGF binding rate − 0.005
ζb Melanocyte bFGF binding rate − 0.02
λ Decay rate of all growth factors - 0.01
Dp Diffusion rate of MMP 5.01× 10−8 cm2/s [58,59] 0.0724
κE Keratinocyte ECM production rate 15.7 pg day
−1 cell−1 0.1
ρE Fibroblast ECM production rate 15.7 pg day
−1 cell−1 0.1
µ ECM decay rate - 0.001
E0 Epidermis ECM density - 0.2
E1 Dermis ECM density - 0.7
assumed to be G0 = 10 ng cm
−3 [64]. We assume that the concentration of growth factors above which
a cell proliferates in normal skin is set to the non-dimensional threshold value 0.02 for Bm, 0.02 for Bf
and 0.01 for Bk. Since the concentrations below which cells die from starvation are also variables, we
set a starvation threshold to be 1% (Sk), 2% (Sm), and 0.1% of the background microenvironmental
concentration G0 for keratinocyte, melanocyte, and abnormal fibroblast respectively.
Experimental methods
Cell culture
Melanoma cells were kindly provided by Dr Meenhard Herlyn (The Wistar Institute, Philadelphia, PA)
and were cultured in RPMI medium supplemented with 5% fetal calf serum (FCS).
Co-culture growth
Senescence was induced in primary fibroblasts following irradiation with 10 Gy followed by 7 days of
recovery as described in Campisi and colleagues [21]. Senescent and pre-senescent fibroblasts were plated
upon 10 cm tissue culture plates overnight before the addition of Adeno-GFP tagged melanoma cells (a
gift from Dr Amer Beg, Moffitt Cancer Center). Images of the growing cells were taken after 24, 48 and
72 hours with a Nikon-TS100 inverted fluorescence microscope.
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Western blotting
Cells were plated and grown overnight. To detect ADAM-9 levels, ADAM-9 antibody (ab) was used
for immunoblotting (IB). For all IB experiments, proteins were denatured prior to separation on 6-18%
Tris-Glycine gels. Proteins were transferred to polyvinylidene fluoride (PVDF) and blocked with 5%
non-fat milk in Tris-Buffered Saline Tween-20 (TBST). Blots were incubated overnight in primary ab
diluted according to the manufacturers instructions. Secondary ab’s conjugated to the enzyme horseradish
peroxidase (HRP) were used for detection by chemiluminescense.
Zymography
Cells were plated and allowed to grow overnight. To detect functional ADAM-9 activity, proteins were
not denatured prior to separation upon a casein gel. Cleavage of casein was imaged using an Epson V300
photo scanner.
Three-dimensional spheroid assays
WM793 melanoma spheroids were prepared using the liquid overlay method [65]. Spheroids were treated
with serum free RPMI, pre-senescent fibroblast conditioned RPMI or senescent fibroblast conditioned
RPMI. Pictures of the invading spheroids were taken using a Nikon-TS100 inverted fluorescence micro-
scope. Images were converted to gray scale and the spheroid frames were outlined using ImageJ (Image
Processing and Analysis in Java) by modifying the threshold. The spheroid frames were than inverted
and absolute intensity of the invading cells was quantified using Adobe Photoshop.
Human specimen procurement
A representative tumor sample was obtained from a patient who underwent surgical resection for metastatic
melanoma and was prospectively consented and accrued to an existing melanoma tissue procurement pro-
tocol approved by the Moffitt Cancer Center Scientific Review Committee and The University of South
Florida Institutional Review Board. After deparaffinization, the slides were stained for ADAM9 (Chemi-
con) before a thorough washing and incubation with a Alexa-Fluor 647 secondary antibody. The slide
was also stained with DAPI to indicate the nuclei and analyzed using a Leica confocal microscope. Areas
of stroma, tumor and leading edge were delineated through examination of corresponding H & E stained
slide by a dermatopathologist.
Initialization
Using the HCA algorithm and parameterization described above, we first ran an initial simulation to
obtain the starting configuration of the domain (Figure 1 B) for all subsequent simulations. We follow
the experimental steps in the in vitro 3D organotypic skin reconstruct experiment Figure 5 A-B, as if
we develop a virtual organotypic skin reconstruct. This 3D organotypic culture system has served as a
foundation for many basic science studies as well as a skin transplantation model, and it is known to
be very stable and homeostatic (see review in [66]). The initial simulation starts with a dermal layer
mixed with fibroblasts that we simulate for two weeks until dermal fibroblasts produce enough growth
factors and ECM for keratinocyte and melanocyte growth. Then a mixed population of keratinocytes
and melanocytes are placed on the top of this matured dermis. As soon as keratinocytes are placed,
they rapidly grow until they fill almost the entire domain. Soon after the most of keratinocytes become
quiescent and start to die. Finally, the population becomes stabilized. The melanocyte population also
rapidly increases initially but soon finds its equilibrium. This initial simulation shows the key interactions
in the model are well balanced and manifest a normal skin homeostasis. Figure 5C shows how the skin
structure develops over the period of a year as well as the concentrations of the microenvironemental
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Figure 5. Organotypic skin and vSkin development. A: Scheme showing the generation of in
vitro orgonotypic skin reconstructs. A stromal layer of collagen mixed with fibroblasts is placed on top
of the acellular collagen, and the layer is incubated for 4 - 7 days to allow the fibroblasts to constrict
the collagen. The epithelial cells are layered on top of the fibroblast-containing stromal layer, and then
the reconstruct is air lifted to promote differentiation and stratification of the epithelial layer. B:
Photomicrograph shows a mature organotypic culture of a normal skin. C: Snapshots of vSkin
initialization. The steps of the simulation follow the same experimental steps used to develop
organotypic skin reconstruct. vSkin development at time step 0, 14 and 365 days are shown in the first
row, and the distributions of growth factors, age and force at the end point (t = 365 days) are shown in
second and third rows.
factors, the age of all cells and the adhesion field after one year. After a period of around 6-8 weeks,
vSkin has already reached a homeostatic configuration. Reassuringly, the timescales of vSkin formation
and the organotypic skin reconstruct are similar. We will utilize the resulting skin structure that emerges
after a year as our initial condition in all subsequent simulations, since the skin structure that naturally
emerged from this initial simulation is morphologically close to real skin.
Skin fitness
The degree of abnormality of vSkin was characterized by a defined metric, “skin fitness (f(t)).” We
quantify ratios of each cell compartment (ratio of keratinocyte to melanocyte and that of fibroblasts to
melanocytes) at each time step (t) and compare with the ratios of the normal state (t0). We also took
changes of epidermal thickness into account to monitor skin fitness. Changes from time step t0 to time
step t (t0 → t) in both compartmental ratios and epidermal thickness were weighted equally to determine
the final skin fitness. The skin fitness is scored from -1 to +1, where +1 represents the maximal fitness
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and a normal skin state, and is defined as follows,
f(t) = 1.0−
(
w1
∆r
r
+ w2
∆h
h
)
, (8)
where r represents the sum of two ratios, the ratio of keratinocyte to melanocyte and that of fibroblast
to melanocyte, ∆ represents the change from time step t0 to t, h stands for a epidermal thickness, and
w1 and w2 are the weights. In this study we choose the same weight (i.e.,w1 = w2 = 0.5).
A B
C D
 0 2 4 6 8 10 12
0
500
1000
1500
2000
2500
3000
3500
Keratinocyte
Fibroblast
Melanocyte
Time (months)
Po
pu
lat
ion
 0 2 4 6 8 10 12
ï50
ï25
0
25
50
75
100
125
150
Time (months)
Ke
ra
tin
oc
yte
 n
et
 g
ro
wt
h
 0 2 4 6 8 10 12
ï4
ï3
ï2
ï1
0
1
2
3
4
Time (months)
Ke
ra
tin
oc
yte
 n
et
 g
ro
wt
h
 0 2 4 6 8 10 12
ï25
ï20
ï15
ï10
ï5
0
5
10
15
20
25
Time (months)
Ke
ra
tin
oc
yte
 n
et
 g
ro
wt
h
M
el
an
oc
yt
e 
ne
t g
ro
w
th
K
er
at
in
oc
yt
e 
ne
t g
ro
w
th
Fi
br
ob
la
st
 n
et
 g
ro
w
th
C
el
l p
op
ul
at
io
n
Time (months)
Time (months) Time (months)
Time (months)
Figure 6. Temporal evolution of each cell population. A: Mean populations dynamics of
keratinocytes, melanocytes and fibroblasts (out of 50 realizations). Both keratinocyte and melanocyte
populations initially increase after placement in the vSkin domain, but after two months the population
is stabilizes. B: A sample of keratinocyte net growth over one year. Keratinocytes proliferate until the
population reaches a maximum in the vSkin domain, then after about two months, keratinocytes start
to commit cell death and the net growth begins to oscillate around zero. C: A sample of melanocyte net
growth over one year. Initially, there are more births than deaths, but soon after the net growth
oscillates around zero. D: A sample of fibroblast net growth over one year.
Results
The vSkin model maintains a stable homeostasis
We already know that our vSkin model can recapitulate normal skin structure. As a typical CA method
inevitably contains stochastic components, multiple realizations (≥ 50) were carried out for each simula-
tion. Our simulations show that vSkin can reach a stable cell net growth rate and total cell number in the
domain. Keratinocytes rapidly grow for the first two months and then reach a stable state (Figure 6 A
and B), while both melanocytes and fibroblasts retain their initial population and the net growth remains
stable (Figure 6 A,C, and D). These data indicate that our vSkin model rapidly achieves and maintains
a stable skin homeostasis.
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Figure 7. Wound healing. A: Positive correlation between healing time and wound size (depth)
derived from a suite of wound healing simulations with a range to different wound depths (average of
100 runs). The healing time was defined as the time it takes for the basement membrane to be
continuously connected. The mean healing time increases as wound size increases. B: Three snapshots
from a wound healing simulation, with a wound that was generated by removing a triangular shape slice
with height of 0.96 mm and width of 1.86 mm.
The vSkin model is robust to physical perturbation
Once the stability of the vSkin model has been established, we next examined its robustness. Two
different types of perturbations were applied to determine the robustness of our model system. First, we
tested if our vSkin model can withstand massive loss of its constituents. To this end, a triangular shaped
injury, which mimics an in vivo puncture wound to the skin, was created in the center of domain. As a
new space was introduced into vSkin, cells nearby the space have an increased tendency to move toward
the new space due to gradient in the force distribution. In the dermal layer, fibroblasts migrate into
the injury site and start to produce growth factors (EGF, TGFβ , and bFGF) and extracellular matrix
proteins. These newly produced growth factors promote growth of keratinocytes in epidermis, thereby
starting to fill the void (healing procedure). A new basement membrane is generated by interactions
between fibroblasts and either keratinocytes or melanocytes. The recovery time was defined as the time
it took the wound site to form a complete basement membrane.
We also changed the size of the wound by increasing injury depth, and quantified the relationship
between healing time and injury size. The recovery time from wounding tends to increase with wound
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size (see Figure 7 A). One hundred realizations were carried out and the mean and standard errors are re-
ported. Interestingly, the variation among realizations increases with wound size. This is presumably due
to the stochastic nature of the cell migration, thereby in basement membrane generation. In other words,
the development of new basement membrane is dependent on chance interactions between fibroblasts and
epidermal cells (keratinocytes or melanocytes). An example snapshot of the wound-healing process is
depicted in Figure 7 B. These wound healing simulations indicate that our vSkin model is robust in the
face of significant physical perturbation. Another implication is that the vSkin model can recapitulate
some basic in vivo skin dynamics.
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Figure 8. Growth factor perturbations and skin fitness. Simulation results from maximizing
(1.0) the concentration of each growth factor over the entire domain during 3, 9, 15 and 21 days
(averaged over 50 runs). After the perturbed skin reaches its new equilibrium, the skin fitness was
measured using (8). The EGF and TGFβ impulses have a negligible effect on skin fitness. The bFGF
and MMP have a greater impact on skin fitness, reducing it to 60% and 0%, respectively. However,
whilst the skin structure is quite close to normal (see upper inset vSkin histology) after bFGF
perturbation, after MMP over-expression, the skin has quite a different structure (see lower inset vSkin
histology)characterized by a lower basement membrane, and the epidermal cells (keratinocytes and
melanocytes) have populated the dermal layer.
The vSkin model returns to equilibrium after biochemical perturbations
The second perturbation involves manipulation of microenvironmental factors to determine if the vSkin
system is robust enough to withstand super-physiological microenvironmental changes. Specifically, each
growth factor was maximized in the domain during 3, 9, 15 and 21 days. The skin fitness function f(t)
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in equation (8) was used to quantify abnormality of vSkin after perturbation. Note that we measure skin
fitness f(t) when vSkin reached a new equilibrium.
When EGF impulses were given to vSkin, keratinocytes responded very quickly. Keratinocytes pro-
liferated until their population saturated the domain and then became quiescent. After most of EGF has
either decayed or been consumed by keratinocytes and melanocytes, the quiescent keratinocytes deprived
of EGF start to die. The resulting skin histology appears to be normal as it preserves normal epidermal
thickness and the normal ratio of melanocytes to keratinocytes. In Figure 8, the blue line shows what
little impact the EGF impulse made on vSkin, even for the longest perturbation time.
The effects of TGFβ impulses on vSkin were also negligible even though the growth of keratinocytes
was inhibited by high TGFβ concentration. This is presumably due to fast turn over rate of keratinocytes.
The light blue line in Figure 8 depicts how the skin fitness changes over different periods of TGFβ
perturbation.
Upon applying bFGF impulses, melanocytes proliferated faster and started to occupy more space than
keratinocytes. The overgrowth of melanocytes resulted in inhibition of growth of keratinocytes due to a
lack of space. When overgrown melanocytes have consumed the excess bFGF, they started to commit
apoptosis. Unlike EGF or TGFβ impulses, vSkin obtained a new equilibrium state with a slight increase
of melanocyte number, particularly near the basement membrane. The overall fitness score is 0.6 as
depicted by the orange line in Figure 8.
Microenvironmental factors can transform normal skin to pathologic skin
Unlike EGF, TGFβ , or bFGF, the overexpression of MMP had profound impact on vSkin fitness. Upon
applying MMP, the extracellular matrix and the basement membrane begin to degrade. Destruction
of the basement membrane increased the probability of melanocytes and keratinocytes to migrate into
the dermal layer. In particular, melanocytes had a higher tendency to migrate into the dermal layer
(a new microenvironment for them) where they can find more growth factors and loss of control from
keratinocytes. This new microenvironment stimulates rapid growth of melanocytes. As a result of MMP
overexpression, the vSkin became thinner with both keratinocytes and melanocytes moving into the
dermal layer (downward). vSkin was able to recover from small changes induced by short term MMP
overexpression (3 days), but fails to compensate for long-term MMP overexpression (9, 15, and 21 days),
as shown in Figure 8.
Collectively, the results indicate our vSkin model is able to return to its original homeostatic state
or to find a new equilibrium in the face of significant microenvironmental deviations; however, this is
dependent upon the perturbations only being to those variables present in normal skin (e.g., EGF, TGFβ ,
and bFGF). When vSkin was disturbed by a factor not typically present in normal skin, its robustness
is dependent on the duration of exposure. With long term exposure of MMP, vSkin transforms to a
pathologic state. This implies that the regulation of microenvironmental factors contributes to vSkin
transformation from a normal to an abnormal, pathologic state.
Homeostatic disruption can lead to melanoma initiation
Our in silico perturbations have shown that vSkin is a robust system which recapitulates normal skin
form and function. These experiments have also shown that bFGF and MMP are important microen-
vironmental regulators in skin homeostasis, particularly in melanocyte homeostasis. Melanocytes are
the cell of origin for one of the most malignant forms of skin cancer, melanoma. A key to understand-
ing melanoma initiation is determining how transformed melanocytes disrupt skin homeostasis. As we
have readily shown in the previous section this homeostasis is crucially dependent on both keratinocyte
regulation of melanocytes as well as microenvironmental regulation. Fibroblasts are the primary source
for many of the microenvironmental factors that regulate skin homeostasis. Therefore, disruption or
transformation of fibroblasts should also have a significant impact on skin homeostasis. Intriguingly,
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Figure 9. Phenotype changes in fibroblasts. A: SA-β-Galactosidase staining where the blue cells
are SA-β-Galactosidase positive (indicating senescence). B: Automated inverted fluorescence images of
pre-senescent (left) and senescent (right) fibroblasts. C: Micro-array analysis shows the fold increase in
expression of multiple proteins in senescent fibroblasts compared to normal fibroblasts. Specific families
of growth factors, proteases and extracellular matrix protein show increased expression. D: Senescent
fibroblasts showed enhanced expression of ADAM9 proteins. E: Zymography shows senescent fibroblasts
enhance matrix degrading capacity.
the major characteristic of transformed melanocytes that distinguishes them from normal melanocytes is
their ability to produce bFGF and MMP. Similarly, we now know that senescent fibroblasts show altered
patterns of ECM expression, growth factor release and protease activity [21].
To investigate this secretory phenotype further we undertook our own experimental investigation
of the changes that occur in fibroblasts when they become senescent. Irradiation (10 Gy) of human
primary skin fibroblasts led to their entry into a senescent-like state, as demonstrated by increased
staining for β-galactosidase (Figure 9A,B). The onset of senescence in the fibroblasts was associated with
a marked change in their mRNA profiles with increases noted in ECM constituents, growth factors and
proteases (Figure 9C). Of these, ADAM9 is a protease thought to be critical for melanoma/fibroblast
interactions [67]. Western blotting demonstrated that ADAM9 expression was highly upregulated in
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Figure 10. Cell interaction network for abnormal skin. Key interactions among normal cells
(keratinocyte, melanocyte, fibroblasts), abnormal cells (senescent fibroblast and transformed
melanocyte) and microenvironmental variables represented as network. Note, cell coloration is used in
all simulations to represent the equivalent cell. Green lines represent promoting events, while red lines
imply inhibiting effects. A transformed melanocyte can produce its own growth factor (bFGF) and
MMP, while senescent fibroblasts can produce bFGF, MMP and extracellular matrix proteins.
senescent fibroblasts compared to non-senescent fibroblasts and that this was associated with increased
matrix degrading capacity (Figure 9D,E). Therefore fibroblasts produce protease, increased levels of
bFGF, and extracellular matrix proteins as they become senescent.
In order to explore the impact of modifying these cell types on homeostasis, we incorporated trans-
formed melanocytes and senescent fibroblasts into the vSkin model. Figure 10 shows how these altered
cell phenotypes modify the cell interaction network, now incorporating normal skin cells, transformed
melanocytes and senescent fibroblasts.
Senescent fibroblasts aid melanocyte proliferation and invasion
To tease apart the relative contributions of the two abnormal cell types we initially look at each of
them separately. First, we studied the role of senescent fibroblasts by examining how the degree of
senescence in a subpopulation of the fibroblasts transforms normal skin structure (Figure 11). The
degree of senescence specifically refers to how much bFGF and MMP the fibroblasts produce, so the most
senescent phenotype produces maximal bFGF and MMP. For each parameter set (bFGF production rate,
MMP production rate), we carried out multiple realizations and quantified skin fitness at each time step
(f(t)) using the average number of each cell compartment and the average epidermal thickness from
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Figure 11. Degree of senescence and its effects on melanocyte growth. Senescent fibroblasts
were placed in the center of the dermal layer, among normal fibroblasts, only 10% were chosen to be
senescent. We considered a range of senescence in terms of the production rate of bFGF and that of
MMP. Specifically, the nondimensional parameter space for senescent fibroblasts was
(αsb, α
s
p) ∈ {(x, y)|0.05 ≤ x ≤ 0.8, 0.0 ≤ y ≤ 0.04}, where αsb represents bFGF production rate by
senescent fibroblasts and αsp indicates MMP production rate by senescent fibroblasts. Multiple
realizations (50) with each parameter set (αsb, α
s
p) were performed, and the mean skin fitness was
quantified at each time step using (8). The first row shows the skin fitness landscapes after two and six
years. A2 and A6 represent skin fitness obtained from simulations with mildly senescent fibroblasts
(bFGF production rate is 0.05 and MMP production rate is 0.01). B2 and B6 show the fitness with
highly senescent fibroblasts (bFGF production rate is 0.8 and MMP production rate is 0.040). Lower
panels show representative vSkin histology for each of these points and highlights how different they are
from normal skin (see figure 10 for a key of color coded cell types).
these realizations. We observed that any degree of senescence for the fibroblasts significantly enhanced
growth of melanocytes and promoted invasion into the dermis. From the skin fitness landscapes (upper
panel, Figure 11) it is clear that the intensity of skin disruption is directly dependent on the degree of
fibroblast senescence. When senescent fibroblasts have weak secretory phenotypes (i.e., close to normal),
the fitness level of the skin they produce is almost one (i.e., normal). The skin structure, however, is
not completely normal as there is some accumulation of matrix near the senescent fibroblasts (see virtual
histology Figure 11, A2). When senescent fibroblasts have stronger secretory phenotypes (B2 and B6)
the melanocyte population expands rapidly and skin fitness deteriorates to -0.4 (B2). Interestingly, the
fitness subsequently increases to 0.0 as time progresses (see the difference between B2 and B6). This
is due to the rapid growth of melanocytes initially (B2), driven by the senescent fibroblasts, but this
excessive growth leads to deprivation of the growth factors for both fibroblasts and keratinocyes (see
Figure 10 for the interdependence of cell types and growth factors) resulting in cell death. Whilst not
cancer, excessive melanocyte production is a key feature of melanoma growth. It is important to note
that the melanocytes here are normal and are only responding to the abnormal microenvironmental cues
being produced by the senescent fibroblasts. However, if these melanocytes were to become transformed
then this would be true melanoma, therefore, senescent fibroblasts may play a critical role in creating an
environment ripe for melanoma initiation.
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Figure 12. Degree of melanocyte malignancy and its effects on melanoma progression. The
degree of melanocyte transformation was varied by increasing production rate of bFGF and MMP. The
parameter range was given as (βsb , β
s
P ) ∈ {(x, y)|0.01 ≤ x ≤ 0.05, 0.0 ≤ y ≤ 0.04}, where βsp represents
bFGF production rate and βsp describes MMP production rate of a transformed melanocyte. The first
row shows the mean skin fitness landscape after 0.25 and 0.5 years (averaged over 50 runs). A0.25,0.5
represents the fitness from simulations with minimally transformed melanocytes (bFGF and MMP
production rates of 0.01), while B0.25,0.5 indicates the fitness achieved with more aggressive melanoma
cells (bFGF production was 0.05 and MMP was 0.04. Lower panels show representative vSkin histology
for each of these points (see figure 10 for a key of color coded cell types).
Transformation of melanocytes drives melanoma initiation
So far, our vSkin simulations have shown that senescent fibroblasts are ideal for disrupting the normal
skin environment to enhance melanocyte proliferation and invasion. However, we know that melanocytes
are significantly transformed in melanoma and so we also need to consider how such mutations will affect
normal skin structure. We therefore integrated phenotypes of mutant melanocytes into the vSkin model
in order to study the role of melanocyte transformation as a driver of melanoma initiation. Note that we
assume all fibroblasts and keratinocytes are normal for these simulations.
Just as we considered a spectrum of senescence in the fibroblast population, we examine a range of
melanocyte transformation. Minimally transformed melanocytes have only lost growth inhibition and
will proliferate even in the absence of bFGF. As malignancy increases, melanocytes gain the ability to
produce bFGF and MMP at ever increasing levels. Therefore degree of malignancy specifically refers
to how much bFGF and MMP the melanocytes produce, so the most malignant phenotype produces
maximal bFGF and MMP. Interestingly, minimally mutated melanocytes (i.e. those that have only lost
proliferative control) remained largely quiescent due to competition for space and growth factors as well
as their inability to invade (results not shown). However, melanocytes with a greater mutational load
proliferated rapidly and invaded taking over the dermal layer of the skin, as shown in Figure 12. and
quantified by the change in fitness landscape at 0.25 years and 0.5 years. Since the more transformed
melanocytes have autocrine signaling, they don’t suffer from growth factor deficiency even with loss of
fibroblasts. With any degree of malignancy, mutant melanocytes significantly lower skin fitness and do so
in a very short time frame, contrast the 0.5 year landscape of Figure 12 to the 6 year landscape of Figure 11.
The effects become more dominant as the degree of transformation increases (A0.25,0.5 → B0.25,0.5). The
mutant melanocytes disintegrate skin structure and completely take over as shown in a sample snapshot
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at B0.5. This vSkin transformation recapitulates a type of melanoma which progresses very rapidly.
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Figure 13. The synergistic effects of senescent fibroblasts and minimally transformed
melanocytes in driving melanoma development. The degree of senescence was varied as in the
Figure 11. The transformed melanocytes (blue) are assumed to be only minimal transformed, i.e., loss
of growth inhibition. Mildly senescent fibroblasts A2,6 still manage to produce a small melanoma nodule
(lower panel) but only impact skin fitness a little (upper panel). However, increasing the fibroblast
senescence significantly impacts melanoma progression, destroying the skin (virtual histology, B2,6) and
reducing the fitness all the way to zero (upper panel). See figure 10 for a key of color coded cell types.
Transformed melanocytes exploit senescent fibroblasts to drive melanoma progression
The next logical step was to integrate both transformed melanocytes and senescent fibroblasts together
in the vSkin model, to investigate how interactions between these abnormal populations drive melanoma
initiation and progression. In order to highlight the impact of these interactions we only considered
minimally transformed melanocytes in the following simulation. It is worth noting that these minimally
transformed melanocytes have only lost control over proliferation and are incapable of producing cancer
in the vSkin model independently since subsequent transformation would be needed for that to occur
(i.e. resulting in increased bFGF and MMP production).
Figure 13 highlights how senescent fibroblasts help transformed melanocytes proliferate more rapidly
and invade into the dermis. Even when minimally transformed melanocytes are combined with the
least senescent fibroblasts in vSkin we see a positive impact on the melanoma growth, with a nodule of
melanocytes (Figure 13A ) forming after 6 years. Increasing the degree of senescence in the fibroblast
population results in a more striking effect with the transformed melanocytes taking over the dermal
layer, especially those nearby senescent fibroblasts (Figure 13B). From these results we can conclude that
strong secretory phenotypes (e.g. the fibroblasts in Figure 13 B2,6) can transform essentially normal
skin (with the exception of the initial mutant melanocyte) to a pathologic state (see density graph B2,6).
Therefore, senescent fibroblasts have the potential to propagate and maintain melanoma development,
provided a minimally transformed melanocyte population already exists.
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Figure 14. Senescent fibroblasts enhance melanoma cell growth and invasion. A: Senescent
fibroblasts aid the growth of early stage (non-tumorigenic) melanoma cells. Equal numbers of
GFP-tagged (green) WM35 melanoma cells were seeded on top of either primary skin human fibroblasts
(pre-senescent) or fibroblasts treated with radiation and allowed to undergo senescence (senescent) and
allowed to grow for 72 hrs. Graph shows the mean (of three independent experiments) relative growth
rates (relative to WM5 cells grown alone) where melanoma cells were plated on top of pre-senescent or
senescent fibroblasts. B: Poorly invasive melanoma cells (WM793) were grown as spheroids alone, in
co-culture with pre-senescent fibroblasts or in co-culture with senescent fibroblasts. The spheroids were
then implanted in collagen and allowed to invade. Mean increases in invasion were calculated using
ImageJ.
In vitro experiments show senescent fibroblasts enhance melanocyte/melanoma
growth and invasion
So far, we have presented vSkin model predictions that senescent fibroblasts change the skin microenvi-
ronment and produce an aberrant skin structure that results from the overgrowth and invasion of normal
melanocytes and early stage melanoma cells. In this section, we compare the model predictions with an
in vitro co-culture assay.
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We explored the prediction that senescent fibroblasts enhanced the growth and invasion of minimally
transformed melanocytes in a series of in vitro fibroblast co-culture models. It was noted that plating early
stage WM35 melanoma cells (which are non-tumorigenic in mice) on top of senescent fibroblasts enhanced
their growth compared to non-senescent fibroblasts (Figure 14 A,B). To study invasion in a tissue-like
context, we next generated spheroids in which poorly invasive melanoma cells (WM793) were co-cultured
with either non-senescent or senescent human skin fibroblasts in a 3D collagen gel (Figure 14 C,D). It was
noted that the WM793 cells invaded the collagen minimally when grown alone and that their invasive
behavior was markedly increased when co-cultured with the senescent fibroblasts. Although not direct
comparison with the vSkin results, our co-culture cell growth assay highlights one of predictions that the
vSkin model makes, which is that senescent fibroblasts promote the growth of early stage melanoma cells.
The potential clinical relevance of our model predictions and experimental findings was suggested by the
observation that human melanoma specimens stained positively for the protease ADAM9 at the leading
edge where the melanoma cells and fibroblasts interact (Figure 15). In contrast, little ADAM9 staining
was noted in the tumor core where stromal infiltration was lacking.
Discussion
The regulation of skin homeostasis involves a complex interplay between different cell types and their
microenvironment. To better understand how these interactions produce skin homeostasis, we developed
a mathematical model that incorporates the key cellular (keratinocytes, melanocytes, and fibroblasts)
and microenvironmental (TGFβ , EGF, bFGF and ECM) components of normal skin. Our virtual skin
model (vSkin) successfully recapitulated normal skin structure, skin homeostasis and wound healing
responses. Surprisingly the homeostasis that emerged from this model was remarkably robust, being
able to recover from both physical and biochemical perturbations. However, the recovery was altered by
both the perturbation type and period. With short-term perturbations inducing increased population
growth, followed by a return to stable homeostasis. More persistent microenvironmental perturbations
(specifically with bFGF) led to an altered but stable homeostatic state characterized by an increased level
of melanocytes. One key perturbation that the system wasn’t robust to was over-production of MMP
and even then it was only when MMP levels were elevated for significant periods of time. Although,
this isn’t too surprising as MMPs are not normally produced in normal skin. These results indicate the
importance of microenvironmental factors in maintaining skin homeostasis and highlight both bFGF and
MMP as key factors in disrupting this homeostasis.
The dialogue between our three cell types, keratinocytes, melanocytes, and fibroblasts is primarily
mediated by growth factors produced by fibroblasts and cell-cell contact. One of the primary reasons for
incorporating fibroblasts into vSkin was to understand their role in normal skin homeostasis, disruption
and cancer initiation. An important experimental observation that motivated this line of inquiry was
that when fibroblasts take on a secretory phenotype (such as that seen when undergoing senescence) they
produce increased levels of bFGF and matrix degrading proteases (Figure 9), the very factors that normal
skin seems to be most sensitive to. By introducing a population of senescent fibroblasts into vSkin we
made the unexpected prediction that such secretory cells may play a central role in the initiation and
progression of melanoma. The least senescent fibroblasts caused a temporary disruption of homeostasis
but as we increased the level of senescence (i.e. increasing the levels of bFGF and MMP production) we
were able to permanently disrupt the skin structure and produced melanocytic hyperplasia i.e. a mole
like structure. However, if the senescent fibroblasts were to be removed, normal skin homeostasis would
be reintroduced since the melanocytes are normal and only reacting to the altered microenvironment
created by the secretory cells.
Our vSkin model is the first model showing all the steps in skin carcinogenesis, from normal skin fol-
lowed by melanocytic hyperplasia, and ending with melanoma. The activation of stroma due to senescence
induces excessive growth of normal melanocytes, resulting in the development of melanocytic hyperpla-
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Figure 15. Melanoma tissue staining. Representative H&E-stained section of a nodule of
metastatic melanoma (upper panel), stained with anti-ADAM9 (lower panel). The yellow line
demarcates the tumor-stroma interface. There is high ADAM9 expression at the tumor/host interface
in the melanoma specimen but weaker, more diffuse expression in the tumor core.
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Figure 16. Multiple routes of Melanoma progression and a potential Anti-MMP therapy.
The total population of transformed melanocytes was quantified for all untreated (upper right) and
Anti-MMP treated (bottom right) cases as a measure of tumor burden. Representative vSkin histology
for each of these cases is also shown (left panels), see figure 10 for a key of color coded cell types. A:
The population of minimally mutated melanocytes (barely visible green line) remains constant. The
most mutated melanocytes produce both bFGF and MMP and progress the most rapidly ((a), dark blue
line). The melanocytes which produce bFGF alone, form melanoma in situ where the melanoma cells
are constrained to the epidermis ((b), light blue line). The most senescent fibroblasts ((c), dark red line)
help minimally mutated melanocytes to proliferate rapidly and progress to full melanoma. Senescent
fibroblasts with weaker secretory phenotypes lead to a slower melanocyte proliferation and invaaion
((d), red line and (e), orange line). B: Melanoma progression after anti-MMP treatment. Anti-MMP
therapy effects the growth of all populations but is more effective for melanoma progression driven by
senescent fibroblasts ((h)-(j)) than melanocyte transformation driven melanomas ((f) and (g)).
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sia (Figure 11). The vSkin model also recapitulated melanoma development driven only by melanocyte
transformation (Figure 12). In addition, the vSkin model proposes alternative routes to melanoma ini-
tiation, by showing that melanoma can occur as a result of co-operation between mutant melanocytes
and senescent fibroblasts (Figure 13). Given that most known driver mutations in melanoma are associ-
ated with entry into oncogene-induced senescence (OIS), our model suggests the possibility that signals
from the senescent stroma may aid melanocyte transformation by allowing them to exit OIS. There is
already good evidence that increased PI3K/AKT signaling can overcome BRAF V600E-induced OIS in
melanocytes [16] and significantly most of the growth factors and altered ECM interactions we describe
here are known to exert their effects through the PI3K/AKT pathway [68].
Biochemical analysis shows that the alterations in senescent fibroblasts included increased expres-
sion of multiple growth factors and proteases. These alterations then stimulated the growth of normal
melanocytes and early stage melanoma cells. The increased level of protease in senescent fibroblasts
enhanced the invasiveness of late stage melanoma cells. Among many proteases, ADAM9 was found to
be a putative mediator of matrix remodeling in senescent dermal fibroblasts. Importantly, the analysis of
ADAM9 expression in melanoma samples from patients revealed that the expression was increased at the
host-tumor interface, but not within the tumor core (Figure 15). Our findings mirror previous studies
implicating a role for ADAM9 expression in melanoma cell/fibroblast interactions at the invasive front
that is required for MMP-1 and MMP-2 mediated matrix degradation [67]. Whilst not conclusive, the
ADAM9 staining implicates the stroma is producing matrix degrading enzymes. This clinical observation
along with all of the experimental results we presented were consistent with our model predictions that
senescent fibroblasts contribute to melanoma initiation and early melanoma progression.
Our vSkin model proposes multiple routes to melanoma initiation and progression, summarized in the
upper panel of Figure 16. The obvious and rapid route shown by the blue lines is due to the accumulation
of mutations in melanocytes to drive melanoma development. The alternative route involves cooperation
of mutant melanocytes with senescent fibroblasts, Figure 16 (red lines). When senescent fibroblasts
stimulate and maintain the excessive growth of minimally transformed melanocytes we observe the slowest
melanoma growth. As senescent fibroblasts adopt stronger secretory phenotypes, melanoma progresses
more rapidly.
If our predictions stand up to future validation, the fibroblasts could represent an important target for
melanoma chemoprevention. The vSkin transformation to melanoma suggests a possible novel treatment,
by negating the influence malignant phenotypes it may be possible to normalize the skin microenvironment
and return (or maintain) skin homeostasis. Since proteases are one of key contributing factors driving
melanoma initiation and progression, both from the senescent fibroblast and transformed melanocyte
perspective, anti-MMP therapy might be a good treatment option. Indeed, there is already evidence
that mutations in MMP-8, leading to an inactivation of protease activity that shifts the pattern of
matrix degradation and growth factor availability, is an important event in the genesis of ∼23% of all
melanomas [69]. As a purely hypothetical exercise we ran a suite of simulations to test this idea, almost
as if we applied anti-MMP cream to the vSkin model such that MMP expression was blocked completely.
Specifically, the MMP level is completely knocked down to zero uniformly in the whole domain, when the
size of initial melanocyte population had doubled. This knock down is maintained until the simulation is
finished. Our in silico anti-MMP treatment experiments show that the treatment was far more effective
for the stroma dependent melanoma in that the population growth rates were significantly decreased (see
Figure 16 (lower panel)).
This study emphasizes the importance of normal skin homeostasis and its disruption in melanoma ini-
tiation and progression. The possible role of MMP inhibition as a chemoprevention strategy for melanoma
will require extensive future experimental validation. MMPs and other related proteases constitute a large
family of enzymes with distinct pro and anti-oncogenic activities. The effective use of MMP blocking
drugs is likely to require an exquisite sensitivity profile that current inhibitors do not yet offer. Our in-
tegrated approach highlighted two key unifying factors in disrupting skin homeostasis, MMP and bFGF
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production. Whether these factors were produced by transformed melanocytes or senescent fibroblasts led
to similar skin degeneration. The most important implication is that we cannot only consider melanoma
as a transformation of the melanocyte population but must also consider the fibroblast population. It is
perhaps no accident then that melanoma really is a disease of the aged [70–72], where fibroblast senes-
cence may naturally occur as we age and aid minor melanocyte mutations (due to a lifetime of skin sun
exposure) to become full blown melanoma.
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